Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trialResearch in context

Autor: Vivianne C.G. Tjan-Heijnen, Senna W.M. Lammers, Sandra M.E. Geurts, Ingeborg J.H. Vriens, Astrid C.P. Swinkels, Carolien H. Smorenburg, Maurice J.C. van der Sangen, Judith R. Kroep, Hiltje de Graaf, Aafke H. Honkoop, Frans L.G. Erdkamp, Wilfred K. de Roos, Sabine C. Linn, Alexander L.T. Imholz

Publikováno v: EClinicalMedicine, Vol 58, Iss , Pp 101901- (2023)

Summary: Background: The DATA study evaluated the use of two different durations of anastrozole in patients with hormone receptor-positive breast cancer who were disease-free after 2–3 years of tamoxifen. We hereby present the follow-up analysis, w

Externí odkaz: https://doaj.org/article/5623c66d14bc4b84bad476914391d5ba

Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA)

Autor: G.A.P. Nieuwenhuijzen, R.A. Hellingman, Franchette W P J van den Berkmortel, S. Hovenga, H.M. Oosterkamp, T. van Dalen, Sabine C. Linn, E.J. van Dulken, Rudi M. H. Roumen, Maurice J.C. van der Sangen, R.C. van Doorn, M.O. den Boer, R. den Toom, Carolien H. Smorenburg, J.J.M. van der Hoeven, Aafke H. Honkoop, Irene E. G. van Hellemond, H. Potthoff, R. Koelemij, Frans L. G. Erdkamp, A. van Bochove, W.G. van Leeuwen-Breuk, R.J.B. Blaisse, A.M.T. van der Velden, Yvonne Kamm, E.J.C. Vriens, Judith R. Kroep, Erik W. Muller, W.J.B. Mastboom, R. van Hillegersberg, P.C. van der Velden, T. van Voorthuizen, Vivianne C. G. Tjan-Heijnen, J.M. Meerum Terwogt, M.M. Vleugel, A. Vos, J.J. Jansen, Jos J. E. M. Kitzen, G.S. Madretsma, R. Vree, J.K.S. Nuytinck, Luc J. A. Strobbe, J.H. van Dam, P.H.A. Nijhuis, Wilfred K. de Roos, P.P.J.B.M. Schiphorst, B. Jas, E.E.M. Schepers, Q. van Rossum-Schornagel, Petronella G. M. Peer, C.J. van Groeningen, J.G. Haasjes, M.J. Agterof, E.A. Kouwenhoven, Alexander L T Imholz, Caroline M. Seynaeve, M.A. Davidis-van Schoonhoven, M.A.J. de Roos, M.J.P.M. Govaert, J.M.A. Ketel, J.M.G.H. van Riel, M. Jagers, A.J. van Overbeeke, Aart Beeker, J.K. Maring, G.J. Veldhuis, J.W.S. Merkus, Maaike de Boer, Onno R. Guicherit, H.B.A.C. Stockmann, E. Janssens van Vliet, J. de Boer, D.F.S. Kehrer, I.E. Arntz, N.G.J. van Diemen, Koop Bosscha, Hiltje de Graaf, F.A.A. Valster, E.E.M. Weernink, C.T.A.M. van Rossum, M.A. van Dijk, B.C. Tanis, Astrid C P Swinkels, E.J.M. Siemerink, D.W. Sommeijer

Publikováno v: Tjan-Heijnen, V C G, van Hellemond, I E G, Peer, P G M, Swinkels, A C P, Smorenburg, C H, van der Sangen, M J C, Kroep, J R, De Graaf, H, Honkoop, A H, Erdkamp, F L G, van den Berkmortel, F W P J, de Boer, M, de Roos, W K, Linn, S C, Imholz, A L T, Seynaeve, C M & Dutch Breast Cancer Research Group (BOOG) for the DATA Investigators 2017, ' Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA) : a randomised, phase 3 trial ', The Lancet Oncology, vol. 18, no. 11, pp. 1502-1511 . https://doi.org/10.1016/S1470-2045(17)30600-9
The Lancet Oncology, 18(11), 1502-1511
Lancet Oncology, 18, 11, pp. 1502-1511
LANCET ONCOLOGY, 18(11), 1502. Lancet Publishing Group
The Lancet Oncology, 18(11), 1502-1511. Lancet Publishing Group
Lancet oncology, 18(11), 1502-1511. Elsevier Science
Lancet Oncology, 18(11), 1502-1511. Lancet Publishing Group
Lancet Oncology, 18, 1502-1511

Item does not contain fulltext BACKGROUND: The effect of extended adjuvant aromatase inhibition in hormone receptor-positive breast cancer after sequential endocrine therapy of tamoxifen followed by an aromatase inhibitor for a 5-year treatment perio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::772ac93cab50bc31223c7dc7ba3cb291
https://doi.org/10.1016/s1470-2045(17)30600-9

Assessment and management of bone health in women treated with adjuvant anastrozole in the DATA study

Autor: Vivianne C. G. Tjan-Heijnen, Alexander L T Imholz, Hiltje de Graaf, Astrid C P Swinkels, Judith R. Kroep, Petronella G. M. Peer, Carolien H. Smorenburg, Maaike de Boer, Aafke H. Honkoop, Caroline M. Seynaeve, Wilfred K. de Roos, Franchette W P J van den Berkmortel, Sabine C. Linn, Frans L. G. Erdkamp, Maurice J.C. van der Sangen, Irene E. G. van Hellemond

534Background: The phase III DATA study (NCT00301457) investigates the efficacy of 6 versus 3 years of adjuvant anastrozole (AI) after an initial 2-3 year treatment with tamoxifen in postmenopausal...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04bd719d94d3f20fcb9a1173cee0afda
https://hdl.handle.net/1887/122852

A Simple Risk Score to Predict the Presence of Non-Sentinel Lymph Node Metastases in Breast Cancer Patients with a Positive Sentinel Node

Autor: Raquel F. D. van la Parra, Miranda F. Ernst, Petronella G. M. Peer, Wilfred K. de Roos, Koop Bosscha, Johannes H. W. de Wilt

Publikováno v: World Journal of Surgery, 38, 5, pp. 1070-6
World Journal of Surgery, 38, 1070-6

Contains fulltext : 137974.pdf (Publisher’s version ) (Closed access) BACKGROUND: Historically, completion axillary lymph node dissection (cALND) is recommended in sentinel lymph node (SLN)-positive patients. However, the high rate of negative non-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2e7bd019f18f502a0b9374072034f34
https://doi.org/10.1007/s00268-013-2387-9

Ultrasound-guided breast-sparing surgery to improve cosmetic outcomes and quality of life. A prospective multicentre randomised controlled clinical trial comparing ultrasound-guided surgery to traditional palpation-guided surgery (COBALT trial)

Autor: Louise de Widt, Wilfred K de Roos, E. Bergers, Sybren L. Meijer, Elly S.M. de Lange-de Klerk, S. Muller, B.M. Zonderhuis, Henk van der Veen, Pieter Poortman, Annette H. M. Taets van Amerongen, A.M. Bosch, Nicole M. A. Krekel, Alexander M F Lopes Cardozo, Mecheline H M van der Linden, Herman Rijna, Petrousjka van den Tol, Hermien Schreurs, Henri A. H. Winters

Publikováno v: BMC Surgery, Vol 11, Iss 1, p 8 (2011)
BMC Surgery, 11:8. BioMed Central
Krekel, N M A, Zonderhuis, B M, Schreurs, H W H, Cardozo, A M F L, Rijna, H, van der Veen, H, Muller, S, Poortman, P, Widt, L, de Roos, W K, Bosch, A M, Taets van amerongen, A H M, Bergers, E, van der Linden, M H M, de Klerk, E S M, Winters, H A H, Meijer, S & van den Tol, M P 2011, ' Ultrasound-guided breast-sparing surgery to improve cosmetic outcomes and quality of life. A prospective multicentre randomised controlled clinical trial comparing ultrasound-guided surgery to traditional palpation-guided surgery (COBALT trial) ', BMC Surgery, vol. 11, 8 . https://doi.org/10.1186/1471-2482-11-8
BMC Surgery

Background Breast-conserving surgery for breast cancer was developed as a method to preserve healthy breast tissue, thereby improving cosmetic outcomes. Thus far, the primary aim of breast-conserving surgery has been the achievement of tumour-free re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84a5215219dd7c35cd7abde2715757a5
http://www.biomedcentral.com/1471-2482/11/8